Dermata Therapeutics Equity Warrant Exp 13th Aug 2026 DRMAW:NASDAQ

RT Quote | USD
Last | 04/11/24 EDT
0.0092quote price arrow down-0.0048 (-34.2857%)
Volume
8,810
52 week range
0.01 - 0.07
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.014
  • 52 Week High0.07
  • 52 Week High Date04/18/23
  • 52 Week Low0.01
  • 52 Week Low Date12/29/23

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.014
  • 52 Week High0.07
  • 52 Week High Date04/18/23
  • 52 Week Low0.01
  • 52 Week Low Date12/29/23
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Dermata Therapeutics Equity Warrant Exp 13th Aug 2026

 

Profile

MORE
Dermata Therapeutics, Inc. is a late-stage medical dermatology company. The Company is focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, both incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its lead product candidate, DMT310, is intended to...
Gerald Proehl
Chairman of the Board, President, Chief Executive Officer
Kyri Van Hoose
Chief Financial Officer, Senior Vice President
Address
3525 Del Mar Heights Rd., #322
San Diego, CA
92130
United States